Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions

Chest. 2005 Jun;127(6):2094-100. doi: 10.1378/chest.127.6.2094.

Abstract

Objectives: The primary aim of this study was to examine the association between pleural fluid (PF) eosinophilia, and the PF and serum levels of interleukin (IL)-5, eotaxin-2, eotaxin-3, and vascular cell adhesion molecule (VCAM)-1 in patients with post-coronary artery bypass grafting (CABG) pleural effusions.

Design: A prospective observational study.

Setting: A tertiary teaching hospital.

Patients and methods: Thirty-eight patients with post-CABG pleural effusions were recruited into the study. An effusion that contained at least 10% eosinophils was called "eosinophilic." The PF and serum levels of the cytokines and VCAM-1 were measured using an enzyme-linked immunosorbent assay.

Results: (1) The number of PF eosinophils significantly correlated with the number of blood eosinophils. (2) PF IL-5 levels were significantly higher than the corresponding serum levels, and there was a significant correlation between the PF and serum IL-5 levels. PF IL-5 levels significantly correlated with the PF eosinophil count, and serum IL-5 levels significantly correlated with the number of blood eosinophils. (3) PF eotaxin-3 levels were significantly higher than serum levels, and PF eotaxin-3 levels significantly correlated with the PF eosinophil count. (4) PF VCAM-1 levels were significantly lower than the corresponding serum levels, and PF VCAM-1 levels were significantly higher in eosinophilic pleural effusions (EPEs) than in non-EPEs.

Conclusion: In patients with post-CABG pleural effusions, IL-5 and eotaxin-3 are produced preferentially in the pleural cavity, and they are strongly associated with PF eosinophilia.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / analysis
  • Chemokine CCL26
  • Chemokines, CC / analysis*
  • Cohort Studies
  • Coronary Artery Bypass / adverse effects*
  • Coronary Artery Bypass / methods
  • Coronary Disease / diagnosis
  • Coronary Disease / surgery
  • Eosinophilia / diagnosis*
  • Female
  • Graft Rejection
  • Graft Survival
  • Humans
  • Interleukin-5 / analysis*
  • Male
  • Pleural Effusion / cytology
  • Pleural Effusion / metabolism*
  • Postoperative Complications / diagnosis*
  • Probability
  • Prognosis
  • Prospective Studies
  • Risk Assessment
  • Sensitivity and Specificity
  • Statistics, Nonparametric

Substances

  • Biomarkers
  • CCL26 protein, human
  • Chemokine CCL26
  • Chemokines, CC
  • Interleukin-5